HAMBURG (dpa-AFX Broker) - Analysts Warburg Research downgraded SNP from "buy" to "hold" in light of the Octapharma offer and the subsequent rise in the share price. The price target was left at 33.00 euros. The offered price of 33.50 euros is only slightly higher than his previous price target, analyst Felix Ellmann argued for the downgrade in a study available on Wednesday./tih/ck

Publication of the original study: 24.05.2023 / 08:15 / CEST

First disclosure of the original study: Date in study not specified / Time in study not specified / CEST

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------